Primary Site >> Esophagus Cancer
Gene >> FASLG
| 1. | |||||||||||
| Journal: | Cancer Res. 1998 May 15;58(10):2057-62. | ||||||||||
| Title: | Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. | ||||||||||
| Author: | Gratas, C|Tohma, Y|Barnas, C|Taniere, P|Hainaut, P|Ohgaki, H | ||||||||||
| PMID: | 9605741 | ||||||||||
| 2. | |||||||||||
| Journal: | J Immunol. 1998 Jun 1;160(11):5669-75. | ||||||||||
| Title: | The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. | ||||||||||
| Author: | Bennett, M W|O'Connell, J|O'Sullivan, G C|Brady, C|Roche, D|Collins, J K|Shanahan, F | ||||||||||
| PMID: | 9605174 | ||||||||||
| 3. | |||||||||||
| Journal: | J Surg Oncol. 1999 Jun;71(2):91-6. | ||||||||||
| Title: | Irradiation-induced up-regulation of Fas in esophageal squamous cell carcinoma is not accompanied by Fas ligand-mediated apoptosis. | ||||||||||
| Author: | Rigberg, D A|Centeno, J|Kim, F S|Ke, B|Swenson, K|Maggard, M|McFadden, D W | ||||||||||
| PMID: | 10389864 | ||||||||||
| 4. | |||||||||||
| Journal: | Dis Esophagus. 1999;12(2):83-9. | ||||||||||
| Title: | Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack. | ||||||||||
| Author: | O'Connell, J|Bennett, M W|O'Sullivan, G C|Collins, J K|Shanahan, F | ||||||||||
| PMID: | 10466039 | ||||||||||
| 5. | |||||||||||
| Journal: | Clin Cancer Res. 1999 Sep;5(9):2464-9. | ||||||||||
| Title: | Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer. | ||||||||||
| Author: | Shibakita, M|Tachibana, M|Dhar, D K|Kotoh, T|Kinugasa, S|Kubota, H|Masunaga, R|Nagasue, N | ||||||||||
| PMID: | 10499620 | ||||||||||
| 6. | |||||||||||
| Journal: | Am J Gastroenterol. 1999 Oct;94(10):2834-9. | ||||||||||
| Title: | Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan. | ||||||||||
| Author: | Wang, L S|Chow, K C|Wu, Y C|Li, W Y|Huang, M H | ||||||||||
| PMID: | 10520830 | ||||||||||
| 7. | |||||||||||
| Journal: | Ann N Y Acad Sci. 2000 Jun;910:178-92; discussion 193-5. | ||||||||||
| Title: | Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict. | ||||||||||
| Author: | O'Connell, J|Bennett, M W|Nally, K|Houston, A|O'Sullivan, G C|Shanahan, F | ||||||||||
| PMID: | 10911913 | ||||||||||
| 8. | |||||||||||
| Journal: | World J Gastroenterol. 2005 Nov 7;11(41):6538-42. | ||||||||||
| Title: | Dual effects of 8-Br-cAMP on differentiation and apoptosis of human esophageal cancer cell line Eca-109. | ||||||||||
| Author: | Wang, Hong-Mei|Zheng, Nai-Gang|Wu, Jing-Lan|Gong, Cui-Cui|Wang, Yi-Ling | ||||||||||
| PMID: | 16425431 | ||||||||||
| 9. | |||||||||||
| Journal: | Zhonghua Yi Xue Za Zhi. 2005 Aug 10;85(30):2132-5. | ||||||||||
| Title: | [Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer]. | ||||||||||
| Author: | Yang, Shen|Miao, Xiao-ping|Zhang, Xue-mei|Sun, Tong|Qu, Shi-ning|Xiong, Ping|Ye, Ying-jiang|Guo, Yong-li|Tan, Wen|Wang, Shan|Lin, Dong-xin | ||||||||||
| PMID: | 16313826 | ||||||||||
| 10. | |||||||||||
| Journal: | J Exp Med. 2005 Oct 3;202(7):967-74. | ||||||||||
| Title: | FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. | ||||||||||
| Author: | Sun, Tong|Zhou, Yifeng|Li, Hua|Han, Xiaohong|Shi, Yuankai|Wang, Li|Miao, Xiaoping|Tan, Wen|Zhao, Dan|Zhang, Xuemei|Guo, Yongli|Lin, Dongxin | ||||||||||
| PMID: | 16186185 | ||||||||||
| 11. | |||||||||||
| Journal: | Folia Histochem Cytobiol. 2007;45(3):199-204. | ||||||||||
| Title: | Serum soluble Fas ligand (sFasL) in patients with primary squamous cell carcinoma of the esophagus. | ||||||||||
| Author: | Kozlowski, Miroslaw|Kowalczuk, Oksana|Sulewska, Anetta|Dziegielewski, Piotr|Lapuc, Grzegorz|Laudanski, Wojciech|Niklinska, Wieslawa|Chyczewski, Lech|Niklinski, Jacek|Laudanski, Jerzy | ||||||||||
| PMID: | 17951168 | ||||||||||
| 12. | |||||||||||
| Journal: | BMC Cancer. 2009 Sep 3;9:310. | ||||||||||
| Title: | Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma. | ||||||||||
| Author: | Takikita, Mikiko|Hu, Nan|Shou, Jian-Zhong|Wang, Quan-Hong|Giffen, Carol|Taylor, Philip R|Hewitt, Stephen M | ||||||||||
| PMID: | 19728877 | ||||||||||
| 13. | |||||||||||
| Journal: | Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Jul;43(7):559-64. | ||||||||||
| Title: | [Genetic polymorphisms in STK15 and MMP-2 associated susceptibility to esophageal cancer in Mongolian population]. | ||||||||||
| Author: | Chen, Xia-Bin|Chen, Guang-Lie|Liu, Jun-Niao|Yang, Jing-Zhong|Yu, Dian-Ke|Lin, Dong-Xin|Tan, Wen | ||||||||||
| PMID: | 19954064 | ||||||||||
| 14. | |||||||||||
| Journal: | Dig Dis Sci. 2013 Jul;58(7):1863-70. | ||||||||||
| Title: | MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. | ||||||||||
| Author: | Wang, Na|Zhang, Chao-Qi|He, Jia-Huan|Duan, Xiao-Fei|Wang, Yuan-Yuan|Ji, Xiang|Zang, Wen-Qiao|Li, Min|Ma, Yun-Yun|Wang, Tao|Zhao, Guo-Qiang | ||||||||||
| PMID: | 23504349 | ||||||||||
| 15. | |||||||||||
| Journal: | PLoS One. 2014 Mar 5;9(3):e90090. | ||||||||||
| Title: | Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies. | ||||||||||
| Author: | Xu, Yeqiong|He, Bangshun|Li, Rui|Pan, Yuqin|Gao, Tianyi|Deng, Qiwen|Sun, Huiling|Song, Guoqi|Wang, Shukui | ||||||||||
| PMID: | 24598538 | ||||||||||
| 16. | |||||||||||
| Journal: | Mol Clin Oncol. 2015 Jan;3(1):151-156. Epub 2014 Sep 26. | ||||||||||
| Title: | Clinical implications of Fas/Fas ligand expression in patients with esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy. | ||||||||||
| Author: | Saigusa, Susumu|Tanaka, Koji|Ohi, Masaki|Toiyama, Yuji|Yasuda, Hiromi|Kitajima, Takahito|Okugawa, Yoshinaga|Inoue, Yasuhiro|Mohri, Yasuhiko|Kusunoki, Masato | ||||||||||
| PMID: | 25469286 | ||||||||||
| 17. | |||||||||||
| Journal: | Am J Cancer Res. 2015 Aug 15;5(9):2865-71. eCollection 2015. | ||||||||||
| Title: | Clinicopathological significance of Fas and Fas ligand expressions in esophageal cancer. | ||||||||||
| Author: | Wu, Guang-Zhou|Pan, Chun-Xia|Jiang, Dong|Zhang, Qiang|Li, Yin|Zheng, Shi-Ying | ||||||||||
| PMID: | 26609492 | ||||||||||
| 18. | |||||||||||
| Journal: | Cancer Med. 2016 Apr;5(4):760-6. | ||||||||||
| Title: | Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population. | ||||||||||
| Author: | Zhang, Meijuan|Wu, Cuiping|Li, Baohuan|Du, Wenjun|Zhang, Chuanzhen|Chen, Ziping | ||||||||||
| PMID: | 26819081 | ||||||||||